ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2013 by Instituto Nacional de Cancer, Brazil
Sponsor:
Information provided by (Responsible Party):
Susanne Crocamo, Instituto Nacional de Cancer, Brazil
ClinicalTrials.gov Identifier:
NCT01472146
First received: September 20, 2011
Last updated: March 4, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2014
  Estimated Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)